Naju, South Korea

Hee Sun Kim

This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Pohang University of Science and Technology Foundation, Korea Institute of Science and Technology, Seoul National University. Active years: 2016-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hee Sun Kim. Retrieved from https://idiyas.com/inventor/hee-sun-kim-jr4feqh1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Naju-si, KR (2016 - 2019)
  • Jeollanam-do, KR (2022)

Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hee Sun Kim: Innovator in Antiviral Pharmaceutical Compounds

Introduction

Hee Sun Kim is a notable inventor based in Naju-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in developing antiviral compounds for treating hepatitis C virus (HCV) related diseases. With a total of four patents to his name, his work has the potential to impact the treatment of liver diseases significantly.

Latest Patents

One of Hee Sun Kim's latest patents is focused on a fluorene derivative or a pharmaceutically acceptable salt thereof, along with a preparation method and a pharmaceutical composition that includes this derivative as an effective ingredient for preventing or treating HCV-related diseases. This invention demonstrates antiviral performance against HCV and its mutants, particularly double mutants. It addresses the issue of resistant mutations against conventional therapeutic agents, making it a promising candidate for treating liver diseases caused by HCV. Another significant patent involves a carbazole compound that exhibits antiviral activity, specifically against HCV. This novel compound shows excellent anti-proliferative efficacy and can be included in pharmaceutical compositions aimed at preventing or treating liver diseases caused by HCV.

Career Highlights

Hee Sun Kim has worked with reputable institutions such as the Postech Academy-Industry Foundation and the Korea Institute of Science and Technology. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Hee Sun Kim has collaborated with notable colleagues, including Sung Key Jang and Gyo Chang Keum. These partnerships have likely enhanced his research capabilities and broadened the impact of his inventions.

Conclusion

Hee Sun Kim's innovative work in developing antiviral compounds positions him as a significant figure in the pharmaceutical industry. His contributions have the potential to improve treatment options for patients suffering from HCV-related liver diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…